4.7 Editorial Material

Maintenance therapy for AML: are we there yet?

Journal

BLOOD
Volume 133, Issue 13, Pages 1390-+

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2019-02-897579

Keywords

-

Categories

Ask authors/readers for more resources

In this issue of Blood, Huls et al present positive results from a randomized study (HOVON97) showing that disease- free survival (DFS) in older patients with acute myeloid leukemia (AML) was improved by azacitidine compared with postremission observation(1).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available